By merging the hub nodes from the PPI network with those from the C–T–P network, we found that AKT1, TNF, JUN, and TP53 were present in all four groups, indicating that they were potentially the core targets of Aloe vera for NASH treatment (Figure 6A). The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatohepatitis.